Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Terence Charles Budge Insider Profile
4 Followers
Terence Charles Budge, Director at Argenica Therapeutics Ltd, holds 805.70K shares in Argenica Therapeutics Ltd (Ticker: AU:AGN).
Terence Charles Budge has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Terence Charles Budge's holdings
Insider Roles
Director
Roles that Terence Charles Budge holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Feb 28, 2022 - Feb 28, 2023
Return:-30.00%
The most profitable trade made by Terence Charles Budge
Terence Charles Budge's Trading History
List of latest transactions for each holding click on a transaction to see Terence Charles Budge's performance on stock
You May Also Like
Terence Charles Budge insider profile FAQ
What is the percentage of profitable transactions made by Terence Charles Budge?
The percentage of profitable transactions made by Terence Charles Budge is ―.
What is the average return per transaction made by Terence Charles Budge?
The average return per transaction made by Terence Charles Budge is ―.
What stocks does Terence Charles Budge hold?
Terence Charles Budge holds: AU:AGN stocks.
What was Terence Charles Budge’s latest transaction?
Terence Charles Budge latest transaction was an Uninformative Sell of AU$95.45K.
What was Terence Charles Budge's most profitable transaction?
Terence Charles Budge’s most profitable transaction was an Informative Buy of AU:AGN stock on February 28, 2022. The return on the trade was -30.00%.
What is Terence Charles Budge's role in Argenica Therapeutics Ltd?
Terence Charles Budge's role in Argenica Therapeutics Ltd is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.